# Respiratory Depression During an Analgosedation Combining Remifentanil and Ketamine in TCI for Oocyte Retrieval

> **NCT03458143** · — · UNKNOWN · sponsor: **Erasme University Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Oocyte Retrieval
- Sedation, Conscious
- Ventilatory Depression

## Interventions

- **DRUG:** Ketamine 150 ng/ml
- **DRUG:** Remifentanil
- **PROCEDURE:** Oocyte retrieval
- **DRUG:** Ketamine 200 ng/ml

## Key facts

- **NCT ID:** NCT03458143
- **Lead sponsor:** Erasme University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-02-12
- **Primary completion:** 2018-03-31
- **Final completion:** 2018-03-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2018-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03458143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03458143, "Respiratory Depression During an Analgosedation Combining Remifentanil and Ketamine in TCI for Oocyte Retrieval". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03458143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*